alpha-Interferon treatment induces quantitative modifications of HLA class I-associated peptides eluted from cultured cancer cell lines.

Cangemi, G; Millo, E; Damonte, G; Semino, C; Pietra, G; Benatti, U; Melioli, G

Cangemi, G; Millo, E; Damonte, G; Semino, C; Pietra, G; Benatti, U; Melioli, G.

Affiliation

Cangemi G; Unità di Immunoterapia Cellulare, Centro di Biotecnologie Avanzate, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

Tissue Antigens ; 55(3): 212-8, 2000 Mar.

Article in En | MEDLINE | ID: mdl-10777096

Subject(s)

Histocompatibility Antigens Class I/metabolism; Interferon-alpha/pharmacology; Peptides/metabolism; Antigens, Neoplasm/metabolism; HLA-A Antigens/metabolism; HLA-B Antigens/metabolism; Humans; K562 Cells; MART-1 Antigen; Melanoma-Specific Antigens; Neoplasm Proteins/metabolism; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Histocompatibility Antigens Class I / Interferon-alpha Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Tissue Antigens Year: 2000 Document type: Article

Search on Google

XML

PubMed Links